A detailed history of Goldman Sachs Group Inc transactions in Pfizer Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 25,826,618 shares of PFE stock, worth $691 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
25,826,618
Previous 34,916,739 26.03%
Holding current value
$691 Million
Previous $977 Million 23.5%
% of portfolio
0.12%
Previous 0.17%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$27.7 - $31.39 $252 Million - $285 Million
-9,090,121 Reduced 26.03%
25,826,618 $747 Million
Q2 2024

Aug 13, 2024

BUY
$25.26 - $29.6 $318 Million - $372 Million
12,569,585 Added 56.25%
34,916,739 $977 Million
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $44.6 Million - $51.2 Million
-1,722,272 Reduced 7.16%
22,347,154 $620 Million
Q4 2023

Feb 13, 2024

SELL
$26.13 - $33.94 $13.4 Million - $17.4 Million
-511,767 Reduced 2.08%
24,069,426 $693 Million
Q3 2023

May 14, 2024

BUY
$32.09 - $37.51 $16.4 Million - $19.2 Million
511,767 Added 2.13%
24,581,193 $815 Million
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $52.2 Million - $61.1 Million
-1,627,801 Reduced 6.21%
24,581,193 $815 Million
Q2 2023

May 14, 2024

BUY
$36.12 - $41.79 $86.6 Million - $100 Million
2,397,511 Added 10.07%
26,208,994 $961 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $86.6 Million - $100 Million
2,397,511 Added 10.07%
26,208,994 $961 Million
Q1 2023

May 14, 2024

SELL
$39.39 - $51.28 $46.2 Million - $60.1 Million
-1,172,040 Reduced 4.69%
23,811,483 $972 Million
Q1 2023

May 11, 2023

SELL
$39.39 - $51.28 $46.2 Million - $60.1 Million
-1,172,040 Reduced 4.69%
23,811,483 $972 Million
Q4 2022

May 14, 2024

BUY
$41.75 - $54.5 $128 Million - $166 Million
3,053,993 Added 13.93%
24,983,523 $1.28 Billion
Q4 2022

Feb 13, 2023

BUY
$41.75 - $54.5 $128 Million - $166 Million
3,053,993 Added 13.93%
24,983,523 $1.28 Billion
Q3 2022

May 14, 2024

BUY
$43.76 - $53.42 $2.79 Million - $3.4 Million
63,669 Added 0.29%
21,929,530 $960 Million
Q3 2022

Nov 10, 2022

BUY
$43.76 - $53.42 $2.79 Million - $3.4 Million
63,669 Added 0.29%
21,929,530 $960 Million
Q2 2022

May 14, 2024

SELL
$46.53 - $55.17 $103 Million - $122 Million
-2,203,565 Reduced 9.16%
21,865,861 $1.15 Billion
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $94.6 Million - $112 Million
2,033,150 Added 10.25%
21,865,861 $1.15 Billion
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $95.6 Million - $119 Million
2,090,429 Added 11.78%
19,832,711 $1.03 Billion
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $36.8 Million - $54.6 Million
-890,845 Reduced 4.78%
17,742,282 $1.05 Billion
Q3 2021

Nov 10, 2021

BUY
$39.25 - $50.42 $731 Million - $939 Million
18,633,127 New
18,633,127 $801 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.